Generali Investments Cee, Investicni Spolecnost, A.S. Biogen Inc. Transaction History
Generali Investments Cee, Investicni Spolecnost, A.S.
- $1.07 Trillion
- Q1 2025
A detailed history of Generali Investments Cee, Investicni Spolecnost, A.S. transactions in Biogen Inc. stock. As of the latest transaction made, Generali Investments Cee, Investicni Spolecnost, A.S. holds 27,060 shares of BIIB stock, worth $3.42 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
27,060
Previous 27,060
-0.0%
Holding current value
$3.42 Million
Previous $4.14 Billion
10.52%
% of portfolio
0.35%
Previous 0.43%
Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,026Shares Held
127MCall Options Held
2.29MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17MShares$2.15 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$2.01 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.84 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$934 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$590 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...